|
|
 |
VABOMERE Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
VANILLIN Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
UREA Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
VARUBI Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|